Bayesian inference for identifying tumour-specific cancer dependencies through integration of ex-vivo drug response assays and drug-protein profiling.
Xing H. and Yau C., (2024), BMC Bioinformatics, 25
Rarity: Discovering rare cell populations from single-cell imaging data.
Märtens K. et al, (2023), Bioinformatics (Oxford, England)
Sociodemographic characteristics and longitudinal progression of multimorbidity: A multistate modelling analysis of a large primary care records dataset in England.
Chen S. et al, (2023), PLoS medicine, 20
The development of a core outcome set for studies of pregnant women with multimorbidity.
Lee SI. et al, (2023), BMC medicine, 21
On the Difficulty of Predicting Engagement with Digital Health for Substance Use.
Günther F. et al, (2023), Studies in health technology and informatics, 302, 967 - 971
An atlas of genetic scores to predict multi-omic traits.
Xu Y. et al, (2023), Nature, 616, 123 - 131
Maternal and child outcomes for pregnant women with pre-existing multiple long-term conditions: protocol for an observational study in the UK.
Lee SI. et al, (2023), BMJ Open, 13
Polypharmacy during pregnancy and associated risk factors: a retrospective analysis of 577 medication exposures among 1.5 million pregnancies in the UK, 2000-2019.
Subramanian A. et al, (2023), BMC Med, 21
Protocol for development and validation of postpartum cardiovascular disease (CVD) risk prediction model incorporating reproductive and pregnancy-related candidate predictors.
Wambua S. et al, (2022), Diagnostic and prognostic research, 6
Epidemiology of pre-existing multimorbidity in pregnant women in the UK in 2018: a population-based cross-sectional study.
Lee SI. et al, (2022), BMC pregnancy and childbirth, 22
Patient Derived Organoids Confirm That PI3K/AKT Signalling Is an Escape Pathway for Radioresistance and a Target for Therapy in Rectal Cancer.
Wanigasooriya K. et al, (2022), Frontiers in oncology, 12
CIDER: an interpretable meta-clustering framework for single-cell RNA-seq data integration and evaluation.
Hu Z. et al, (2021), Genome biology, 22
Protocol for the development of a core outcome set for studies of pregnant women with pre-existing multimorbidity.
Lee SI. et al, (2021), BMJ open, 11
Adipocyte-like signature in ovarian cancer minimal residual disease identifies metabolic vulnerabilities of tumor-initiating cells.
Artibani M. et al, (2021), JCI insight, 6
Promises and challenges of adoptive T-cell therapies for solid tumours.
Morotti M. et al, (2021), British journal of cancer, 124, 1759 - 1776
The Oxford Classic Links Epithelial-to-Mesenchymal Transition to Immunosuppression in Poor Prognosis Ovarian Cancers.
Hu Z. et al, (2021), Clinical cancer research : an official journal of the American Association for Cancer Research, 27, 1570 - 1579